Anuh Pharma Limited (BOM:506260)

Anuh Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 3, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	7,624	7,459	12,308	3,990	4,307	4,525
Market Cap Growth	-15.01%	-39.39%	208.46%	-7.36%	-4.82%	54.95%
Enterprise Value	7,495	7,081	11,824	3,486	4,209	4,202
Last Close Price	76.07	73.17	119.27	38.08	40.42	41.97
PE Ratio	18.22	15.75	20.49	11.03	14.09	15.91
PS Ratio	0.99	1.13	1.90	0.76	0.89	1.05
PB Ratio	2.33	2.29	4.23	1.65	2.02	2.37
P/TBV Ratio	2.33	2.29	4.23	1.66	2.02	2.38
P/FCF Ratio	-	43.93	155.62	7.62	15.81	-
P/OCF Ratio	-	20.09	95.22	7.40	14.92	-
EV/Sales Ratio	0.98	1.07	1.83	0.66	0.87	0.97
EV/EBITDA Ratio	12.91	11.21	15.78	6.56	8.74	9.54
EV/EBIT Ratio	15.21	12.89	17.68	7.97	11.52	14.23
EV/FCF Ratio	-	41.71	149.51	6.66	15.45	-
Debt / Equity Ratio	0.00	0.03	0.01	0.00	0.02	0.07
Debt / EBITDA Ratio	0.00	0.17	0.04	0.02	0.09	0.31
Debt / FCF Ratio	-	0.64	0.34	0.02	0.16	-
Net Debt / Equity Ratio	-0.04	-0.19	-0.20	-0.22	-0.10	0.00
Net Debt / EBITDA Ratio	-0.22	-0.99	-0.79	-0.98	-0.44	0.01
Net Debt / FCF Ratio	-	-3.68	-7.53	-1.00	-0.77	-0.02
Asset Turnover	-	1.39	1.52	1.40	1.43	1.31
Inventory Turnover	-	6.76	6.64	5.34	4.72	4.66
Quick Ratio	-	1.68	1.69	1.42	1.23	0.98
Current Ratio	-	2.11	2.22	1.91	1.98	1.71
Return on Equity (ROE)	-	15.34%	22.56%	15.90%	15.11%	16.12%
Return on Assets (ROA)	-	7.21%	9.83%	7.27%	6.72%	5.60%
Return on Invested Capital (ROIC)	11.72%	17.23%	24.38%	17.46%	14.87%	13.18%
Return on Capital Employed (ROCE)	-	16.70%	22.80%	17.90%	16.90%	15.30%
Earnings Yield	5.49%	6.35%	4.88%	9.07%	7.10%	6.28%
FCF Yield	-	2.28%	0.64%	13.12%	6.33%	-5.50%
Dividend Yield	0.99%	1.03%	1.05%	2.63%	2.17%	1.79%
Payout Ratio	-	26.45%	16.69%	24.18%	24.73%	-
Total Shareholder Return	1.04%	1.03%	1.05%	2.63%	2.17%	1.79%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.